1. Home
  2. MTX vs ZLAB Comparison

MTX vs ZLAB Comparison

Compare MTX & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Minerals Technologies Inc.

MTX

Minerals Technologies Inc.

HOLD

Current Price

$77.91

Market Cap

2.2B

Sector

Industrials

ML Signal

HOLD

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

HOLD

Current Price

$17.74

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MTX
ZLAB
Founded
1968
2013
Country
United States
China
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.4B
IPO Year
2004
2017

Fundamental Metrics

Financial Performance
Metric
MTX
ZLAB
Price
$77.91
$17.74
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$82.00
$49.60
AVG Volume (30 Days)
214.5K
654.4K
Earning Date
04-30-2026
05-07-2026
Dividend Yield
0.68%
N/A
EPS Growth
N/A
38.46
EPS
1.17
N/A
Revenue
$2,072,600,000.00
$460,156,000.00
Revenue This Year
$5.66
$9.75
Revenue Next Year
$4.47
$26.03
P/E Ratio
$66.48
N/A
Revenue Growth
N/A
15.33
52 Week Low
$53.15
$15.96
52 Week High
$84.34
$44.34

Technical Indicators

Market Signals
Indicator
MTX
ZLAB
Relative Strength Index (RSI) 55.44 36.85
Support Level $65.38 $16.88
Resistance Level $84.34 $19.64
Average True Range (ATR) 2.25 0.81
MACD -0.26 -0.16
Stochastic Oscillator 40.19 3.30

Price Performance

Historical Comparison
MTX
ZLAB

About MTX Minerals Technologies Inc.

Minerals Technologies Inc mines, produces, and sells mineral-based products. The firm organizes itself into two segments: The Consumer & Specialties segment that derives maximum revenue, serves consumer end markets directly with mineral-to-market finished products and also provides specialty mineral-based solutions and technologies that are an essential component of its customers' finished products; and The Engineered Solutions segment serves industrial end markets with engineered systems, mineral blends, and technologies that are designed to improve its customers' manufacturing processes and projects. The majority of revenue comes from the United States, while it also has its presence in Canada/Latin America, Europe/Africa, and Asia.

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

Share on Social Networks: